Efficacy and safety of MP1032 plus standard-of-care compared to standard-of-care in hospitalised patients with COVID-19: a multicentre, randomised double-blind, placebo-controlled phase 2a trial

https://www.thelancet.com/journals/lanepe/article/PIIS2666-7762(23)00229-6/fulltext?dgcid=hubspot_email_covidalerts&utm_campaign=lancetcovid22&utm_medium=email&_hsmi=286691763&_hsenc=p2ANqtz-_Pd6xzkeEOiJCMl0bJfHhwJLna2cj31On0NHxLZtT00AZXp9UF9L3xvbA3JeZRwulHbp6UWQaZED3p5J4TTK55pD4rOg&utm_content=286678291&utm_source=hs_email